Using federal funds to provide gender-affirming care is prohibited under the budget reconciliation package known as the One Big, Beautiful Bill Act.

The FDA says it plans to use artificial intelligence to help speed the approval of new drugs and medical devices.

Gender-affirming care may have positive effects, but those with co-existing psychiatric diagnoses must be carefully monitored through treatment.

Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.

Abdominal fat mass index was strongly associated with obstructive sleep apnea risk across demographic subgroups, including racial and BMI categories.

HealthDay News — Health care employment growth decreased during the pandemic but recovered by 2024, according to a research letter published online June 5 in the Journal of the American Medical ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with ...

Treatments for multiple myeloma, melanoma, NSCLC, phenylketonuria, C3 glomerulopathy and primary immune complex ...

The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

The risk of cardiotoxicity may vary across CDK4/6 inhibitors, according to a study of patients with breast cancer.